Market Place
Sourcing Support
Akorn’s bankruptcy, recalls bring a drug to treat lead poisoning into shortage
27 Jul 2023 //
ENDPTS
Akorn Issues Voluntary Nationwide Recall of Various Human & Animal Drug Products
03 May 2023 //
BUSINESSWIRE
After Akorn`s site closures in the US, albuterol remains in shortage
31 Mar 2023 //
ENDPTS
Akorn`s closure pressures already strained supplies of albuterol
10 Mar 2023 //
FIERCE PHARMA
Akorn Pharmaceuticals files for bankruptcy, closes facilities and will liquidate
02 Mar 2023 //
ENDPTS
Bankrupt Akorn Pharma calls it quits and closes all US sites
23 Feb 2023 //
FIERCE PHARMA
Akorn Introduces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg
27 Oct 2022 //
PRNEWSWIRE
Pharmaceutical Company Akorn Agrees to Pay $7.9 Million
16 Sep 2022 //
JUSTICE
Akorn to pay almost $8M after selling OTC drugs under obsolete prescription
15 Sep 2022 //
ENDPTS
Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg
16 Aug 2022 //
PRNEWSWIRE
Théa to Acquire Branded Ophthalmic Products from Akorn
28 Jan 2022 //
BUSINESSWIRE
Prestige to acquire Akorn’s consumer product portfolio for $230m
28 May 2021 //
PHARMACEUTICAL-TECHNOLOGY
Akorn Announces Agreement to Sell its Consumer Health Business
27 May 2021 //
PRNEWSWIRE
Akorn Announces Review of Strategic Alternatives for the Akorn
26 Feb 2021 //
PRNEWSWIRE
Akorn Receives FDA Approval for Loteprednol Etabonate Ophthalmic Gel, 0.5%
11 Feb 2021 //
PRNEWSWIRE
Akorn finalizes sale to lenders and exits Chapter 11 protection
02 Oct 2020 //
SEEKINGALFA
Once valued at $4B, an embattled Akorn — nursing a market cap of roughly $37M
21 May 2020 //
ENDPTS
Midazolam Injection, USP -Drug shortage
10 Apr 2020 //
FDA
Flexion secures China deal for osteoarthritis drug; Struggling
01 Apr 2020 //
ENDPTS
Akorn Announces New Extension of Standstill with Lenders
12 Feb 2020 //
PR NEWSWIRE
Akorn and lenders negotiate its future again
12 Feb 2020 //
FIERCE PHARMA
Akorn Continues Negotiations with Lenders
10 Feb 2020 //
PR NEWSWIRE
Akorn Receives FDA Approval for Azelastine Hydrochloride Nasal Spray, 0.15%
26 Aug 2019 //
GLOBENEWSWIRE
Akorn inks $74M settlement over data integrity woes
02 Aug 2019 //
FIERCE PHARMA
FDA Warns Akorn for Repeat Violations
09 Jul 2019 //
RAPS
Akorn takes on second FDA warning letter with companywide action plan
01 Jul 2019 //
IN-PHARMATECHNOLOGIST
Teetering Akorn hit with another FDA warning letter
26 Jun 2019 //
FIERCE PHARMA
Akorn’s losses narrow but clock is ticking with lenders
08 May 2019 //
FIERCE PHARMA
Akorn receives good news after manufacturing network blow
05 Mar 2019 //
IN-PHARMATECHNOLOGIST
Akorn`s New York sterile drug plant hit by FDA
01 Mar 2019 //
FIERCE PHARMA
FDA flags sanitation concerns at Akorn`s Amityville plant
28 Feb 2019 //
REUTERS
Akorn gets FDA warning letter for Illinois plant, shares drop
10 Jan 2019 //
REUTERS
Akorn CEO exits after failing to salvage Fresenius deal
11 Dec 2018 //
FIERCE PHARMA
Fentanyl Billionaire No More: John Kapoor`s Net Worth Drops Below $1B
07 Dec 2018 //
FORBES
Akorn fights to salvage Fresenius deal in appeal to Delaware Supreme Court
07 Dec 2018 //
FIERCE PHARMA
Judge Rules Fresenius was Right to Terminate Merger With Akorn
02 Oct 2018 //
RAPS
Fresenius alleges ‘blatant fraud at the very top level’ of Akorn operations
08 May 2018 //
FIERCE PHARMA
Akorn Accused of Sending Phony Data to FDA on Antibiotic
03 May 2018 //
BLOOMBERG
Fresenius Alleges Akorn Knowingly Submitted Fraudulent Testing Data to FDA
02 May 2018 //
RAPS
Fresenius dumps $4.3B Akorn buyout, sparking legal brouhaha
23 Apr 2018 //
FIERE PHARMA
Lieff Cabraser Announces Securities Class Action Against Akorn, Inc.
21 Mar 2018 //
BUSINESSWIRE
Insys founder Kapoor steps down as Akorn chairman after arrest
01 Nov 2017 //
REUTERS
Akorn Shareholders Vote to Approve Merger Agreement with Fresenius Kabi
19 Jul 2017 //
GLOBENEWSWIRE
Eton Pharmaceuticals Names Sean Brynjelsen Chief Executive Officer and Director
23 Jun 2017 //
PR NEWSWIRE
Merck sells biosimilars business to Fresenius
26 Apr 2017 //
PHARMA TIMES
Fresenius nabs Akorn, Merck KGaA biosimilars in $5.4B double play
25 Apr 2017 //
FIERCE PHARMA
Fresenius Buys Akorn for $4.3 Billion in U.S. Expansion
24 Apr 2017 //
BLOOMBERG
Fresenius Kabi To Buy Akorn; To Acquire Merck KGaA`s Biosimilars Business
24 Apr 2017 //
NASDAQ
MEDA to Shut Down Facility But Employees Could Land a Gig at Akorn Pharma
25 Mar 2017 //
BIOSPACE
Akorn Announces Completion of FDA Re-inspection of Decatur Facility
12 Dec 2016 //
GLOBENEWSWIRE
Akorn launches ibuprofen oral suspension
01 Dec 2016 //
PHARMABIZ
NYPD Union Goes After Drug Prices Amid DOJ Pharma Probe
18 Nov 2016 //
BLOOMBERG
Paulson Triples Stakes in Endo, Akorn as Other Hedge Funds Sell
16 May 2016 //
BLOOMBERG
Pfizer restricts use of its medicines for prison executions
14 May 2016 //
STAT
Drug price increases saw `high water mark` year in 2015: Analysts
07 Jan 2016 //
FIERCE PHARMA
Akorn introduces Myorisan 30 mg capsules
30 Sep 2015 //
PHARMABIZ
Akorn Launches Acetylcysteine Injection
09 Jul 2015 //
AKORN
Pharmaceutical Firm Wants Lethal Injection Drugs Returned
08 May 2015 //
ABC NEWS
Up and Down the Ladder: The Latest Comings and Goings at Valeant, Novo and…
02 May 2015 //
THE WALL STREET JOURNAL
High-flyer Akorn crashes on earnings restatement as shareholders sue en masse
28 Apr 2015 //
FIERCE ANIMAL HEALTH
